Literature DB >> 18404365

Hox-D genes expression in pediatric low-grade gliomas: real-time-PCR study.

Anna Maria Buccoliero1, Francesca Castiglione, Duccio Rossi Degl'Innocenti, Franco Ammanati, Flavio Giordano, Massimiliano Sanzo, Federico Mussa, Lorenzo Genitori, Gian Luigi Taddei.   

Abstract

HOX genes encode transcription factors, which play a key role in morphogenesis and cell differentiation during embryogenesis. Several observations indicate that a deregulated expression of these genes may result in tumor development and progression. Actually, several HOX genes are aberrantly expressed in many tumors and cell lines derived from them. Little is known about the expression of HOX genes in brain tumors. In the present work, we study the relative expression of HOX-D genes (D1, D3, D4, D8, D9, D10, D11, D12, D13) with real-time polymerase chain reaction in a group of 14 pediatric low-grade gliomas. We compare the HOX-D expression level of the 14 tumors with the average expression level of six non-neoplastic human brain tissues. HOX-D1 and HOX-D12 resulted over-expressed in neoplastic samples with respect to non-neoplastic brain parenchyma. Conversely, HOX-D3 was expressed at a lower level in gliomas with respect to non-neoplastic brain. HOX-D4, HOX-D11, and HOX-D13 were never expressed. HOX-D8, HOX-D9, and HOX-D10 were exceptionally expressed in non-neoplastic samples and irregularly expressed in tumors. The observation that all but three HOX-D genes studied are expressed with different pattern in neoplastic and non-neoplastic brain tissue may support the hypothesis that HOX-D genes play a role in the pathogenesis of pediatric low-grade gliomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18404365     DOI: 10.1007/s10571-008-9282-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Finger and toe ratios in humans and mice: implications for the aetiology of diseases influenced by HOX genes.

Authors:  J T Manning; M Callow; P E Bundred
Journal:  Med Hypotheses       Date:  2003-03       Impact factor: 1.538

3.  Organization of human homeobox genes.

Authors:  E Boncinelli; R Somma; D Acampora; M Pannese; M D'Esposito; A Faiella; A Simeone
Journal:  Hum Reprod       Date:  1988-10       Impact factor: 6.918

4.  HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas.

Authors:  Masahiko Shiraishi; Azumi Sekiguchi; Adam J Oates; Michael J Terry; Yuji Miyamoto
Journal:  Oncogene       Date:  2002-05-16       Impact factor: 9.867

5.  Cloning, expression and chromosomal location of NKX6B TO 10Q26, a region frequently deleted in brain tumors.

Authors:  S H Lee; J A Davison; S M Vidal; A Belouchi
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

6.  Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.

Authors:  B Bodey; B Bodey; S E Siegel; H E Kaiser
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

7.  Expression of folate pathway genes in the cartilage of Hoxd4 and Hoxc8 transgenic mice.

Authors:  Claudia Kruger; Catherine Talmadge; Claudia Kappen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-04

8.  Up-to-date monitoring of childhood cancer long-term survival in Europe: central nervous system tumours.

Authors:  V Arndt; P Kaatsch; E Steliarova-Foucher; R Peris-Bonet; H Brenner
Journal:  Ann Oncol       Date:  2007-08-20       Impact factor: 32.976

9.  Induction of the angiogenic phenotype by Hox D3.

Authors:  N Boudreau; C Andrews; A Srebrow; A Ravanpay; D A Cheresh
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

10.  Hoxd1 is expressed by oligodendroglial cells and binds to a region of the human myelin oligodendrocyte glycoprotein promoter in vitro.

Authors:  Jayaum Booth; Danette J Nicolay; J Ronald Doucette; Adil J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 4.231

View more
  9 in total

1.  Effect of overexpression of HOX genes on its invasive tendency in cerebral glioma.

Authors:  Yun-Bao Guo; Yi-Meng Shao; Jing Chen; Song-Bai Xu; Xing-Dong Zhang; Mao-Ren Wang; Hai-Yan Liu
Journal:  Oncol Lett       Date:  2015-11-09       Impact factor: 2.967

2.  Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells.

Authors:  Masanao Tabuse; Shigeki Ohta; Yohei Ohashi; Raita Fukaya; Aya Misawa; Kazunari Yoshida; Takeshi Kawase; Hideyuki Saya; Cécile Thirant; Hérve Chneiweiss; Yumi Matsuzaki; Hideyuki Okano; Yutaka Kawakami; Masahiro Toda
Journal:  Mol Cancer       Date:  2011-05-22       Impact factor: 27.401

3.  HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines.

Authors:  Jin Wook Kim; Ji Young Kim; Ja Eun Kim; Seung-Ki Kim; Hyun-Tai Chung; Chul-Kee Park
Journal:  Genes Cancer       Date:  2014-05

4.  Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.

Authors:  Qiangwei Wang; Zhiliang Wang; Guanzhang Li; Chuanbao Zhang; Zhaoshi Bao; Zheng Wang; Gan You; Tao Jiang
Journal:  Aging (Albany NY)       Date:  2018-08-15       Impact factor: 5.955

5.  Systematic analysis of enhancer regulatory circuit perturbation driven by copy number variations in malignant glioma.

Authors:  Jun Xiao; Xiaoyan Jin; Chunlong Zhang; Haozhe Zou; Zhenghong Chang; Nan Han; Xia Li; Yunpeng Zhang; Yongsheng Li
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

6.  Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme.

Authors:  Yanxin Li; Ke Ma; Qi Xie; Xianwei Zhang; Xiulei Zhang; Kui Chen; Lingfei Kong; Rongjun Qian
Journal:  Onco Targets Ther       Date:  2021-10-27       Impact factor: 4.147

7.  Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes.

Authors:  Buze Chen; Cui Gao; Haihong Wang; Jieyun Sun; Zhengxiang Han
Journal:  Comput Math Methods Med       Date:  2022-09-29       Impact factor: 2.809

8.  Clinicopathological analysis of HOXD4 expression in diffuse gliomas and its correlation with IDH mutations and 1p/19q co-deletion.

Authors:  Xin-Wei Zhao; Yun-Bo Zhan; Jian-Ji Bao; Jin-Qiao Zhou; Feng-Jiang Zhang; Yu Bin; Ya-Hui Bai; Yan-Min Wang; Zhen-Yu Zhang; Xian-Zhi Liu
Journal:  Oncotarget       Date:  2017-12-18

9.  Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.

Authors:  Young-Bem Se; Seung Hyun Kim; Ji Young Kim; Ja Eun Kim; Yun-Sik Dho; Jin Wook Kim; Yong Hwy Kim; Hyun Goo Woo; Se-Hyuk Kim; Shin-Hyuk Kang; Hak Jae Kim; Tae Min Kim; Soon-Tae Lee; Seung Hong Choi; Sung-Hye Park; Il Han Kim; Dong Gyu Kim; Chul-Kee Park
Journal:  Cancer Res Treat       Date:  2016-07-19       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.